Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in BRIDGEBIO PHARMA INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 451,016 shares of BBIO (BRIDGEBIO PHARMA INC), worth $34.5M as of 2025-Q4. The position was decreased (-12.1% shares). BBIO represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$34.5M
Current Shares
451,016
Total Value Change
+$16.6M
Total Shares Change
-255,111
Other major holders of BBIO: BNP PARIBAS FINANCIAL MARKETS, VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC
Decreased |
| 451,016 |
-12.1% |
| $34.5M |
| 0.0% |
| $75.48 |
0 |
| 2025-Q3 | Decreased | 513,263 | -27.1% | $26.7M | 0.0% | $51.96 | 0 |
| 2025-Q2 | Increased | 704,357 | +16.4% | $30.4M | 0.0% | $44.86 | 33 |
| 2025-Q1 | Decreased | 604,946 | -0.8% | $20.9M | 0.0% | $35.11 | 0 |
| 2024-Q4 | Decreased | 609,588 | -7.7% | $16.7M | 0.0% | $27.32 | 0 |
| 2024-Q3 | Decreased | 660,265 | -6.5% | $16.8M | 0.0% | $24.94 | 0 |
| 2024-Q2 | Increased | 706,127 | +10.0% | $17.9M | 0.0% | $25.33 | 31 |